Medical XpressNew stem cell method produces millions of human brain and muscle cells in daysMedical XpressHuman pluripotent stem cells offer the ability to create any tissue, including those which are typically hard to access, such as brain cells. They… Continue reading
Digital TrendsScientists May Have Found A Way To Make Old Stem Cells Act …Digital TrendsNobody likes getting older. Reversing some of the bad aspects of the process helps us all age gracefully. The suggestion that young blood may be the key to … Continue reading
|
Next Big Future: CRISPR/Cas9 Reveals Cancer’s Synthetic Lethal …
Next Big Future Synthetic-lethal gene interactions may occur when certain pairs of mutated genes are present. When there is a mutation in either of these genes within a cell, the … |
Next Big Future |
CRISPR gene therapy is enhancing t-cell immnotherapy treatment of cancer and treatments in people could be …
Next Big Future 2. the targeted nature of CRISPR-mediated CAR integration into the genome might “prove safer than random integration, which carries the potential risk of generating a harmful mutation,” Dr. Maus wrote. 3. It could enable off-the-shelf CAR T cells to be … CRISPR Gene-Editing: Moving Outside Our Bodies and Into the WorldBU News Service Gene Research: New Discoveries And The Latest NewsThe Missouri Injury Blog (blog) |
FiercePharma |
Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy Bavencio
FiercePharma Pfizer, Merck KGaA score watershed FDA nod on cancer immunotherapy Bavencio. by Tracy Staton |. Mar 23, 2017 4:55pm. Pfizer HQ. Pfizer paid $850 million up front to Merck KGaA to set up a cancer immunotherapy partnership, and Thursday’s FDA … FDA Grants Approval for BAVENCIO® (avelumab), the First Immunotherapy Approved for Metastatic Merkel Cell …Yahoo Finance Pfizer (PFE) and Merck (MRK) BioPharma Unit Get FDA Approval for BAVENCIO® (Avelumab), the 1st Immunotherapy …StreetInsider.com Avelumab: First Drug Ever Approved for Merkel Cell CarcinomaMedscape |